You are here: Industry Insights > Roche

News List

Roche forced to extend Spark tender offer as investors sue over $4.3B merger fiercepharma
April 04, 2019
Roche’s $114.50-per-share offer for Spark Therapeutics represents a whopping 122% premium to the gene specialist’s
Roche’s ipatasertib combo shows early promise in triple-negative breast cancer pharmatimes
April 04, 2019
Roche has announced results from a Phase Ib trial assessing its AKT-inhibitor ipatasertib, Tecentriq (atezolizumab) and chemotherapy in triple-negative breast cancer (TNBC), showing a 73% overall response rate irrespective of PD-L1 status.
FDA approves Roche's Tecentriq in combination with chemotherapy for the initial treatment of adults with extensive-stage small cell lung cancer worldpharmanews
March 21, 2019
Roche announced that FDA approved Tecentriq® (atezolizumab), in combination with carboplatin and etoposide (chemotherapy) for the initial (first-line) treatment of adults with extensive-stage small cell lung cancer (ES-SCLC).
Venclexta trial deaths force AbbVie, Roche to stop recruiting myeloma patients fiercepharma
March 20, 2019
AbbVie and Roche are looking to move key oncology drug Venclexta deeper into the blood cancer arena, but their ambitions in multiple myeloma just took a hit.
EC approves Roche’s MabThera for a rare autoimmune disease biospectrumasia
March 19, 2019
MabThera is the first biologic treatment approved for moderate to severe cases of the rare autoimmune disease pemphigus vulgaris (PV), and the first major advancement in the treatment of the disease in more than 60 years
Roche's MabThera garners EU clearance as first biologic therapy for pemphigus vulgaris firstwordpharma
March 15, 2019
The FDA approved MabThera in June last year for the treatment of patients with PV.
Roche’s Tecentriq notches win in breast cancer with US approval expressbpd
March 14, 2019
The FDA’s OK was based on a trial that showed the drug cocktail helped stave off the disease’s advance by a median 7.4 months, compared to 4.8 months with chemotherapy
Roche gets FDA’s accelerated approval to Tecentriq for TNBC biospectrumasia
March 12, 2019
Roche has announced that the US Food and Drug Administration (FDA) has granted accelerated approval to Tecentriq® (atezolizumab) plus chemotherapy (Abraxane® [paclitaxel protein-bound particles for injectable suspension (albumin-bound); nab-paclitaxel]) f
US company claims Irish firm Amgen infringing cancer drug patent firstwordpharma
March 12, 2019
Roche's Genentech unit has filed a lawsuit in the US accusing Amgen of infringing a patent covering the cancer drug Avastin, Irish Examiner reported Monday.
Roche's I-O drug Tecentriq picks up key first-in-class breast cancer nod fiercepharma
March 12, 2019
In a first for the immuno-oncology field, Roche’s Tecentriq has a big new approval in breast cancer. And once again, the Swiss drugmaker has nabbed a piece of the immuno-oncology market all for itself.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 45 46 Next page